Malignant Lymphomas

Key points
- The malignant lymphomas are a group of lymphoproliferative disorders that are usually divided into Hodgkin's disease and the non-Hodgkin's lymphomas.
- An experienced hematopathologist is required to distinguish some forms of non-Hodgkin's lymphoma from Hodgkin's disease.
- These two disease entities have markedly different clinical characteristics.
- For instance, Hodgkin's lymphomas commonly occur as localized areas of lymph node enlargement.
The malignant lymphomas are a group of lymphoproliferative disorders that are usually divided into Hodgkin's disease and the non-Hodgkin's lymphomas. These two disease entities have markedly different clinical characteristics. For instance, Hodgkin's lymphomas commonly occur as localized areas of lymph node enlargement. They tend to spread to contiguous lymph node groups and do not commonly involve extranodal sites of disease. Further, they are cured in more than 75% of the cases. Non-Hodgkin's lymphomas tend to be disseminated at presentation, will spread in a discontinuous fashion, and frequently involve extranodal areas. Further, the cure rates remain in the 30% to 40% range. The cell of origin in the non-Hodgkin's lymphomas is usually a B cell but occasionally a T cell. The cell of origin in Hodgkin's disease remains unknown.
An experienced hematopathologist is required to distinguish some forms of non-Hodgkin's lymphoma from Hodgkin's disease. However, the importance of the subclassification of the non-Hodgkin's lymphomas is critical, as is detailed later.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsMany adolescent girls with leukemia are not being screened for pregnancy before beginning chemotherapy
A new study indicates that adolescent females with acute leukemia have low rates of pregnancy screening prior to receiving chemotherapy that can cause birth defects. The findings are published early online in CANCER, a…
12 October 2016
NewsE-cigarette vapor does not cause oxidative stress in viable lung epithelial cells
E-cigarette vapour is much less harmful to lung cells than cigarette smoke . Lab tests show that, unlike tobacco smoke, which causes oxidative stress and cell death, e-cigarette vapour does not. Oxidative stress and…
5 October 2016
NewsAnti-tumor immunity identified with new ovarian cancer treatment strategy
Few effective treatments have been approved to treat ovarian cancer , the deadliest of all cancers affecting the female reproductive system. Now, new research from The Wistar Institute demonstrates how a drug already in…







